Non-Invasive Prenatal Testing (NIPT)

Plasma is isolated from specialized blood tubes that preserve cell-free DNA (cfDNA) from genomic contamination.

This cfDNA, containing a mix of maternal and fetal DNA is extracted from the plasma and tagged for use in sequencing.

NIPT uses whole-genome next-generation sequencing (NGS) technology. The test analyzes cfDNA fragments across the whole genome, which has advantages over other NIPT methodologies, including targeted sequencing and array-based tests.

All of this data is then compiled onto our easy to read report, and available to the provider in real time via our online portal.

Required Documents for NIPT:

Helpful Documents for NIPT:

Additional Options (for Single Pregnancies Only)

Microdeletions: Wolf-Hirschhorn syndrome, cri-du-chat syndrome, Prader-Willi syndrome/Angelman syndrome, DiGeorge syndrome

All Chromosomes (Includes sex chromosome aneuploidies)

Insurance requirements vary for additional options*

Single Pregnancies

Chromosome 13 (Patau Syndrome)

Chromosome 18 (Edward's Syndrome)

Chromosome 21 (Down Syndrome)

Sex Chromosome Aneuploidies: MX, XXX, XXY, and XYY

Twin Pregnancies

Chromosome 13 (Patau Syndrome)

Chromosome 18 (Edward's Syndrome)

Chromosome 21 (Down Syndrome)

Presence of Y chromosome